Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001104659-25-100081·CK Life Sciences Intl (Holdings) Inc
Schedule 13D ownership disclosure
TRANSCODE THERAPEUTICS INC
Common Stock · CUSIP: 89357L501
Event date: 2025-10-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CK Life Sciences Int'l., (Holdings) Inc.Reported CIK 0001297567
Shares: 83,285.00 · Class: 9.1%
- DEFJ, LLC
Shares: 83,285.00 · Class: 9.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-100081
- Form type
- SCHEDULE 13D
- Filer
- CK Life Sciences Intl (Holdings) Inc
- CIK
- CIK 1297567
- Filed
- Oct 16, 2025
- Reporting period
- Oct 08, 2025
- Description
- Schedule 13D beneficial ownership